BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 16595166)

  • 1. Thiomers: preparation and in vitro evaluation of a mucoadhesive nanoparticulate drug delivery system.
    Bernkop-Schnürch A; Weithaler A; Albrecht K; Greimel A
    Int J Pharm; 2006 Jul; 317(1):76-81. PubMed ID: 16595166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thiomer nanoparticles: stabilization via covalent cross-linking.
    Barthelmes J; Dünnhaupt S; Hombach J; Bernkop-Schnürch A
    Drug Deliv; 2011 Nov; 18(8):613-9. PubMed ID: 22111974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and in vitro evaluation of surface modified poly(lactide-co-glycolide) nanoparticles with chitosan-4-thiobutylamidine.
    Grabovac V; Bernkop-Schnürch A
    Drug Dev Ind Pharm; 2007 Jul; 33(7):767-74. PubMed ID: 17654025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a novel method for the preparation of thiolated polyacrylic acid nanoparticles.
    Greindl M; Bernkop-Schnürch A
    Pharm Res; 2006 Sep; 23(9):2183-9. PubMed ID: 16952008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distribution of thiolated mucoadhesive nanoparticles on intestinal mucosa.
    Dünnhaupt S; Barthelmes J; Hombach J; Sakloetsakun D; Arkhipova V; Bernkop-Schnürch A
    Int J Pharm; 2011 Apr; 408(1-2):191-9. PubMed ID: 21295123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of vehicles on the mucoadhesive properties of orally administrated nanoparticles: a case study with chitosan-4-thiobutylamidine conjugate.
    Sakloetsakun D; Perera G; Hombach J; Millotti G; Bernkop-Schnürch A
    AAPS PharmSciTech; 2010 Sep; 11(3):1185-92. PubMed ID: 20668967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thiolated hydroxyethyl cellulose: design and in vitro evaluation of mucoadhesive and permeation enhancing nanoparticles.
    Rahmat D; Müller C; Barthelmes J; Shahnaz G; Martien R; Bernkop-Schnürch A
    Eur J Pharm Biopharm; 2013 Feb; 83(2):149-55. PubMed ID: 23148989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of a mucoadhesive nanoparticulate drug delivery system for a targeted drug release in the bladder.
    Barthelmes J; Perera G; Hombach J; Dünnhaupt S; Bernkop-Schnürch A
    Int J Pharm; 2011 Sep; 416(1):339-45. PubMed ID: 21726619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination of SEDDS and Preactivated Thiomer Technology: Incorporation of a Preactivated Thiolated Amphiphilic Polymer into Self-Emulsifying Delivery Systems.
    Hetényi G; Griesser J; Nardin I; Bernkop-Schnürch A
    Pharm Res; 2017 Jun; 34(6):1171-1179. PubMed ID: 28283859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation of thiomer microparticles and in vitro evaluation of parameters influencing their mucoadhesive properties.
    Albrecht K; Zirm EJ; Palmberger TF; Schlocker W; Bernkop-Schnürch A
    Drug Dev Ind Pharm; 2006; 32(10):1149-57. PubMed ID: 17090437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of chitosan-6-mercaptonicotinic acid nanoparticles for oral peptide drug delivery.
    Millotti G; Perera G; Vigl C; Pickl K; Sinner FM; Bernkop-Schnürch A
    Drug Deliv; 2011 Apr; 18(3):190-7. PubMed ID: 21039318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thiolated polymers--thiomers: synthesis and in vitro evaluation of chitosan-2-iminothiolane conjugates.
    Bernkop-Schnürch A; Hornof M; Zoidl T
    Int J Pharm; 2003 Jul; 260(2):229-37. PubMed ID: 12842342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and characterization of pH tolerant and mucoadhesive (thiol-polyethylene glycol) chitosan graft polymer for drug delivery.
    Hauptstein S; Bonengel S; Griessinger J; Bernkop-Schnürch A
    J Pharm Sci; 2014 Feb; 103(2):594-601. PubMed ID: 24382680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mucus permeating thiomer nanoparticles.
    Köllner S; Dünnhaupt S; Waldner C; Hauptstein S; Pereira de Sousa I; Bernkop-Schnürch A
    Eur J Pharm Biopharm; 2015 Nov; 97(Pt A):265-72. PubMed ID: 25603199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preactivated thiolated nanoparticles: A novel mucoadhesive dosage form.
    Menzel C; Bonengel S; Pereira de Sousa I; Laffleur F; Prüfert F; Bernkop-Schnürch A
    Int J Pharm; 2016 Jan; 497(1-2):123-8. PubMed ID: 26631639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design and in vitro evaluation of a novel polymeric excipient for buccal applications.
    Laffleur F; Shahnaz G; Islambulchilar Z; Bernkop-Schnürch A
    Future Med Chem; 2013 Apr; 5(5):511-22. PubMed ID: 23573970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comprehensive in vitro and in vivo evaluation of thiolated matrix tablets as a gastroretentive delivery system.
    Senyigit ZA; Vetter A; Guneri T; Bernkop-Schnürch A
    Drug Deliv; 2011 Aug; 18(6):405-14. PubMed ID: 21463156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a novel method for the preparation of submicron particles based on thiolated chitosan.
    Bernkop-Schnürch A; Heinrich A; Greimel A
    Eur J Pharm Biopharm; 2006 Jun; 63(2):166-72. PubMed ID: 16527469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. pH-responsive thiolated chitosan nanoparticles for oral low-molecular weight heparin delivery: in vitro and in vivo evaluation.
    Fan B; Xing Y; Zheng Y; Sun C; Liang G
    Drug Deliv; 2016; 23(1):238-47. PubMed ID: 24865290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thiolated polymers--thiomers: development and in vitro evaluation of chitosan-thioglycolic acid conjugates.
    Kast CE; Bernkop-Schnürch A
    Biomaterials; 2001 Sep; 22(17):2345-52. PubMed ID: 11511031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.